Canine Stem Cell Therapy Market 2020 Growth Analysis

1. Canine Stem Cell Therapy Market 2020- Segment Analysis, Opportunity Assessment, Competitive Intelligence, Industry Outlook 2026 Canine stem cell therapy is a disease-modifying therapy used for the treatment of degenerative disorders such as arthritis of hips, elbows, shoulders, etc. Factors like rising prevalence of canine arthritis and increasing investment in research and development are expected to accentuate the growth of the canine stem cell therapy market. However, stem cell therapy is an expensive procedure as compared to other treatment options and this is impeding the growth of the market. Moreover, the lack of pet insurance will further restrain the growth of the market. Get a Sample copy of Canine stem cell therapy market 2016-26 Report at: https://www.alltheresearch.com/report/206/canine-stem-cell-therapy-market Based on application, the treatment segment is expected to dominant the market during the forecast period Based on applications, the market has been segmented into treatment and research. The treatment segment accounts for the largest share in the global canine stem cell therapy market by application. The rising prevalence of canine arthritis is driving the growth of this market segment. The increasing penetration of pet insurance and growing awareness about stem cell therapy will lead to the rising adoption of stem cell therapy and thereby, drive the treatment segment of the market. Based on the end-user, the veterinary clinics segment is expected to dominate during the forecast period Based on the end-user, the market has been segmented into veterinary hospitals, veterinary clinics, and veterinary research institutes. The veterinary clinics segment accounts for the largest share in the market and held more than 60% of the total market in 2018. The increasing number of veterinary clinics offering stem cell therapy will drive the growth of this end-user segment. Furthermore, there has been an expansion in the number of veterinary clinic chains, which has made treatment more accessible over a wide geography. This will also drive the growth of the veterinary clinics end-user segment.

2. We are incorporating the IMPACT of the COVID-19 on the Market in every report as value added section To know more please visit @ https://www.alltheresearch.com/report/206/canine-stem-cell-therapy-market North America to dominate the global canine stem cell therapy market throughout the forecast period North America accounted for the highest share in 2018 and is expected to continue its dominance in the market throughout the forecast period. North America has the highest population of pet dogs, with around 73 million dogs in the US and over 6 million in Canada. The rising pet ownership in this region is one of the most important factors driving the growth of this market. The US accounted for around 90% of the market in 2018. The rising research and development activity in this region will also augment the growth of the canine stem cell therapy market. Company Profiles and Competitive Intelligence: The major players operating in this market are VetStem Biopharma, Medrego, and Magellan Stem Cells, amongst others. Most of the companies are conducting clinical trials to study the safety and efficacy of stem cells for various indication such as spinal disorders, renal disorders, etc. About AlltheResearch: AllTheResearch was formed with the aim of making market research a significant tool for managing breakthroughs in the industry. As a leading market research provider, the firm empowers its global clients with business-critical research solutions. The outcome of our study of numerous companies that rely on market research and consulting data for their decision-making made us realize, that it’s not just sheer data-points, but the right analysis that creates a difference. For all your Research needs, reach out to us at: 39180 Liberty Street Suite 110, Fremont, CA 94538, USA Email: contactus@alltheresearch.com US: 1-888-691-6870